LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38 | -99.9% | 572 | 0.0% | 0.00% | – |
| Q3 2022 | $49,000 | +157.9% | 572 | +155.4% | 0.00% | – |
| Q2 2022 | $19,000 | -24.0% | 224 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -45.7% | 224 | -24.8% | 0.00% | – |
| Q4 2021 | $46,000 | +70.4% | 298 | +49.0% | 0.00% | – |
| Q3 2021 | $27,000 | -22.9% | 200 | -26.2% | 0.00% | – |
| Q2 2021 | $35,000 | -12.5% | 271 | 0.0% | 0.00% | – |
| Q1 2021 | $40,000 | +53.8% | 271 | 0.0% | 0.00% | – |
| Q4 2020 | $26,000 | +52.9% | 271 | +39.0% | 0.00% | – |
| Q3 2020 | $17,000 | +54.5% | 195 | +107.4% | 0.00% | – |
| Q2 2020 | $11,000 | +22.2% | 94 | -26.0% | 0.00% | – |
| Q1 2020 | $9,000 | +800.0% | 127 | +1170.0% | 0.00% | – |
| Q4 2019 | $1,000 | -96.3% | 10 | -95.3% | 0.00% | – |
| Q1 2019 | $27,000 | +285.7% | 213 | +294.4% | 0.00% | – |
| Q4 2018 | $7,000 | -53.3% | 54 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | +36.4% | 54 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |